Cubicin

 

Topic mentions per year

Topic mentions per year

2003-2016
024620032016

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
OBJECTIVES Two randomized Phase I studies in separate populations of healthy adult volunteers investigated the pharmacokinetics… (More)
Is this relevant?
2009
2009
OBJECTIVES The rate of infection in patients who require ventricular assist devices (VADs) is estimated at more than 35… (More)
Is this relevant?
2007
2007
The Cubicin Outcomes Registry and Experience (CORE), was designed to retrospectively collect the real-world postmarking… (More)
Is this relevant?
2007
2007
Data from a registry were analyzed to describe the clinical experience with daptomycin (Cubicin; Cubist Pharmaceuticals, Inc… (More)
Is this relevant?
2007
2007
A registry describing daptomycin's clinical use was analyzed to describe treatment of skin and skin-structure infections (SSSIs… (More)
Is this relevant?
2006
2006
Daptomycin, a cyclic lipopeptide produced by Streptomyces roseosporus, is the active ingredient of Cubicin (daptomycin-for… (More)
  • figure 1
  • figure 2
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2006
2006
Daptomycin is a lipopeptide antibiotic produced by Streptomyces roseosporus and recently commercialized as Cubicin (daptomycin… (More)
Is this relevant?
2005
2005
 
Is this relevant?
Highly Cited
2004
Highly Cited
2004
Daptomycin is a cyclic anionic lipopeptide antibiotic recently approved for the treatment of complicated skin infections (Cubicin… (More)
  • figure 4
  • table 1
  • figure 5
  • figure 6
Is this relevant?
2004
2004
Two in vitro studies assessed the potential of daptomycin (Cubicin), a newly marketed antibiotic, to affect the cytochrome P450… (More)
Is this relevant?